Berlusconi immunity law revoked
 |
Berlusconi's corruption trial in Milan will have to resume.
Story Tools
|
ROME, Italy (Reuters) -- Italy's Constitutional Court has ruled that a recent law which gave Prime Minister Silvio Berlusconi immunity from prosecution was illegitimate and had to be revoked, a court statement said.
The decision represented a severe setback for Berlusconi and means that a corruption trial in Milan, where he is accused of bribery and which was frozen last June when parliament approved the law, will now have to resume.
Italy's top court ruled that the controversial legislation ran counter to the principal enshrined in the Italian constitution that everyone should be equal before the law.
The hotly-contested legislation awarded Italy's top five officials, including the president and prime minister, legal immunity during their term in office.
Critics accused the government of drawing up the bill to prevent a potentially damaging verdict falling during Italy's presidency of the European Union, which ended in December.
Berlusconi's allies say the prime minister is facing a witch-hunt by politically-motivated magistrates and say the immunity law was similar to legislation in other EU states.
While the case against Berlusconi was frozen in June, the trial of his co-defendants continued.
It culminated in a verdict in November with judges rejecting the central accusation that one of the prime minister's companies had bribed judges to win a favorable ruling in a 1980s corporate takeover.
However, they found that one of Berlusconi's former lawyers, his close friend Cesare Previti, had handed over cash to a powerful Rome judge to keep him on friendly terms with the firm. Previti was sentenced to five years in jail.
He is appealing against the verdict.
It was not immediately clear when Berlusconi's trial might resume.
The panel of judges that heard the original trial for more than three years have since struck themselves off the case which means new judges will now have to pick up the reins.
Copyright 2004
Reuters. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
